Healthcare Trust America Incorporated (NYSE:HTA) had an increase of 5.11% in short interest. HTA’s SI was 12.33 million shares in September as released by FINRA. Its up 5.11% from 11.73 million shares previously. With 1.36M avg volume, 9 days are for Healthcare Trust America Incorporated (NYSE:HTA)’s short sellers to cover HTA’s short positions. The SI to Healthcare Trust America Incorporated’s float is 8.61%. About 505,400 shares traded. Healthcare Trust Of America Inc (NYSE:HTA) has risen 7.80% since September 13, 2016 and is uptrending. It has underperformed by 8.90% the S&P500.

Healthcare Trust of America, Inc. is a real estate investment trust. The company has market cap of $6.21 billion. The Firm is an owner and operator of medical office buildings in the United States. It has a 142.33 P/E ratio. The Firm focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Among 11 analysts covering Healthcare Trust of America (NYSE:HTA), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Healthcare Trust of America had 26 analyst reports since August 26, 2015 according to SRatingsIntel. The stock of Healthcare Trust Of America Inc (NYSE:HTA) has “Hold” rating given on Thursday, April 13 by BMO Capital Markets. Morgan Stanley initiated Healthcare Trust Of America Inc (NYSE:HTA) on Wednesday, December 9 with “Equal-Weight” rating. Mizuho upgraded Healthcare Trust Of America Inc (NYSE:HTA) on Wednesday, January 4 to “Buy” rating. The rating was upgraded by Raymond James to “Outperform” on Monday, November 7. The stock has “Buy” rating by BMO Capital Markets on Tuesday, July 18. The firm earned “Buy” rating on Thursday, August 25 by BTIG Research. The stock of Healthcare Trust Of America Inc (NYSE:HTA) earned “Buy” rating by Stifel Nicolaus on Thursday, December 31. The company was initiated on Thursday, September 10 by BMO Capital Markets. Oppenheimer maintained the stock with “Outperform” rating in Tuesday, August 2 report. The firm has “Outperform” rating given on Tuesday, June 20 by BMO Capital Markets.